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Abstract
Background Even though allergies are an important
health issue, wide manufacturer-dependent differ-
ences in the detected amounts of allergen-specific
IgE (sIgE) have repeatedly been found. These discrep-
ancies hinder diagnostics and research into clinically
significant cutoff points for life-threatening symp-
toms.
Methods To evaluate whether the reported differences
have led to changes in diagnostic testing, we ana-
lyzed data from six years of round robin testing (RRT,
also known as proficiency testing) at the Gesellschaft
zur Förderung der Qualitätssicherung in medizini-
schen Laboratorien e.V. (Society for Promoting Qual-
ity Assurance in medical Laboratories) for the impor-
tant allergen sources bee venom, wasp venom, and
birch pollen. The results of the four main suppliers
of in vitro diagnostic sIgE testing were compared in
a pseudo-anonymized form using overlay images of
box plot graphs for the semiquantitative data and al-
lergen class results. Coefficients of variation (CV) were
obtained to study the development of interlaboratory
comparability.
Author´s contribution N. Wojtalewicz performed the
statistical analysis, generated the figures, and wrote the
paper. S. Goseberg collected and pooled the INSTAND e. V.
data. K. Kabrodt corrected the paper and I. Schellenberg is
the corresponding author as well as the EQA expert for in
vitro allergy round robin tests. He is also vice president of
INSTAND e. V.
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Results We found that the large differences between
the manufacturer collectives remained constant be-
tween January 2010 and April 2015 without any real
improvement. The CVs were good for two of the four
analyzed suppliers, one was marginal and one above
the quality level of 20%.
Conclusion The numerous publications that have
found discrepancies in the sIgE results of the different
suppliers did not change the status quo within the
last six years. Unfortunately, this is unlikely to change
until there is a characterized standard material with
known values of sIgE.
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Abbreviations
CCD Cross-reactive carbohydrate structure
CV Coefficient of variation
INSTAND Gesellschaft zur Förderung der Quali-
tätssicherung in medizinischen Labo-
ratorien (Society for Promoting Quality
Assurance in medical Laboratories)
RfB Reference Institute for Bioanalytics
RRT Round robin test
sIgE Specific IgE
Introduction
Allergies have become more prevalent among global
populations within the last 50 years [1]. In Germany,
about 49% of adults have specific IgE antibodies (sIgE)
against at least one of the 50 allergens tested [2].
Allergic rhinitis (14.8%) and asthma bronchiale
(8.6%) have the highest lifetime prevalence in Ger-
many [3]. These two diseases are often caused by
outdoor allergens [4] such as birch pollen, against
which 17.4% of allergy patients exhibit sIgE [2]. Aller-
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gies to hymenoptera venoms – for example from the
honeybee or the yellow jacket (hereinafter referred to
as bee and wasp venom) – represent a special allergic
disease. This disease is far less prevalent, representing
around 2.8% of cases [3]. However, despite this low
rate of incidence, hymenoptera stings are reported to
be the trigger in about 50% of all anaphylaxis cases in
German-speaking countries [5]. This emphasizes the
importance of having an accurate diagnosis for these
allergens so that precautions can be taken before the
first life-threatening reaction occurs.
The Gesellschaft zur Förderung der Qualitätssiche-
rung in medizinischen Laboratorien (Society for Pro-
moting Quality Assurance in medical Laboratories)
(INSTAND e. V.) has managed round robin tests (RRTs,
also known as proficiency testing) for in vitro allergy
diagnostics since 1995 and is one of two officially ap-
pointed reference institutes in Germany. In 2003, it
reported large discrepancies between the sIgE levels
detected by systems from different manufacturers [6].
Since then, multiple studies addressing this problem
have been published, comparing up to three differ-
ent systems with a variety of serum samples. While
some publications point out the differences between
the testing methods [7–9], other laboratories report
a good comparability for several allergen sources [10,
11]. A recent publication by Koch & Aberer evaluated
the development of the allergen class results from the
last 25 years and found good agreements between the
laboratories [12]. But the good comparability of the al-
lergen classes can be quite confusing, since they can
sometimes mask high differences within the kU/L re-
sults [13]. The importance of the quality management
in in vitro diagnostics is a frequently discussed topic,
as shown by a recent review article by Kleine-Tebbe
et al. [14]. This way, a constant attention is directed
towards the sIgE-diagnostic and this should forward
the effort for a better comparability.
To analyze possible changes within in vitro allergy
diagnostics, we evaluated the data from six years of
RRTs at INSTAND e. V. for the allergen sources birch
pollen, bee venom, and wasp venom. This paper is
the first presenting the chronological development of
differences in detection levels. The analysis provides
insights into semiquantitative results in kU/L, corre-
sponding allergen classes, and interlaboratory com-
parability.
Materials and methods
Round robin testing procedures at INSTAND e. V.
Every participant receives five lyophilized serum sam-
ples for each RRT. Four samples are used to determine
sIgE against inhaled allergens, food allergens, and hy-
menoptera venoms allergens, and one to determine
total IgE. Three sera show high levels of sIgE, while
two are dilutions from both sera for the determina-
tion of sIgE.
Each participant has to determine the allergen class
and the sIgE concentrations (kU/L) of the defined al-
lergen sources like birch pollen.
In order to evaluate sIgE concentrations, the results
are sorted according to the manufacturer of the sys-
tem. These groups of participants are referred to as
“collectives”. The median for each collective is calcu-
lated after determining the clinically relevant range.
Every participant whose results are within 25% of the
median passes the evaluation and receives a certifi-
cate.
In terms of the allergen classes, the results are gen-
erally comparable among the manufacturers so that
they can be evaluated for all participants within the
RRT. Only when the results of one manufacturer col-
lective lie within a completely different range, a sepa-
rate median is formed for this collective. As with the
concentration, every participant that is within 25% of
the median passes the test and receives a certificate.
Furthermore, the coefficient of variation of the re-
sults within the evaluation is obtained for every collec-
tive in order to evaluate the interlaboratory variance
for the serum sample.
Data evaluation
For this publication, data from 17 RRTs carried out
between 2010 and 2015 were analyzed for the allergen
sources bee venom, wasp venom, and birch pollen.
Between 140 and 460 participants took part in the dif-
ferent RRTs for the individual allergens. Each dataset
was sorted according to manufacturer collective and
then plotted as a box plot. This paper used all of the
results except for the outliers that exceeded the high-
est calibration point of each collective by more than
20% (kU/L) or 0.5 allergen classes, respectively. The
manufacturer code can be found in the RRT̕s sup-
plementary booklet. Basic statistical analyses were
performed using SigmaPlot 13 from Systat Software
GmbH (Erkrath, Germany).
Generation of images
The overlay images were generated using the Gnu im-
age manipulator software 2.8.1.
Results
This publication includes data on the three allergen
sources birch pollen, bee venom, and wasp venom
from 17 RRTs performed between January 2010 and
April 2015. Both venoms were tested in all RRTs and
birch pollen was included in 12 RRTs. During this time
period, the number of participants increased from
around 140 in 2010 to about 500 participants in 2015.
While the pass rate for the allergen class results re-
mained relatively constant at around 90%, the pass
rate for the semiquantitative sIgE determination rose
from between 50 and 80% in 2010 to nearly 95% start-
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Fig. 1 Manufacturer distribution for sIgE results of theallergen
source birch pollen in the round robin test conducted in April
2015 for concentrated (a) anddiluted (b) sample. Thegreenbox
indicates25–75%ofall valuescombined. Thered linemarksthe
medianofallvaluescombined,andthegreenlinesthegeneral10
and 90 percentiles. Manufacturers with fewer than four partici-
pantsaresummarizedas“other”. Theboxindicatesthe25–50%
values, while the whiskers display the 10 and 90 percentiles of
eachcollective
Fig. 2 Timeline of the results of sIgE against birch pollen aller-
gensfrom2010to2015forsemiquantitativeanalysisofconcen-
trated (a) and diluted sample (b) as well as for the RAST (radio-
allergosorbenttest)classesofconcentrated(c)anddilutedsam-
ple (d). The grey boxes display all results from the respective
roundrobintest. Theresultsobtainedwiththespecificmanufac-
turercollectivesare illustratedascolored10to90percentilebox
plots. F7 is coloredblue, F48orange, F64 red, andF138green
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Fig. 3 Timeline of the results of sIgE against bee venom aller-
gensfrom2010to2015forsemiquantitativeanalysisofconcen-
trated (a) and diluted sample (b) as well as for the RAST (radio-
allergosorbenttest)classesofconcentrated(c)anddilutedsam-
ple (d). The grey boxes display all results from the respective
roundrobintest. Theresultsobtainedwiththespecificmanufac-
turercollectivesare illustratedascolored10to90percentilebox
plots. F7 is coloredblue, F48orange, F64 red, andF138green
ing in early 2014. Nevertheless, this high pass rate
for the semiquantitative analysis was only possible
because the evaluation used manufacturer collectives
due to the low comparability of the different detection
systems (data not shown).
There was a great divergence in the detected
amounts of sIgE, especially for birch pollen, as shown
in the concentrated (Fig. 1a) and diluted sample
(Fig. 1b) of the RRT from April 2015.
As expected, the combined results from all partic-
ipants showed a very wide range of values (from 0 to
~65 kU/L). When the results are separated into sup-
plier collectives, severemanufacturer-dependent vari-
ations emerge for the concentrated sample. While the
results of the manufacturers F7, F62, F64, and F148
are between 0 and 15 kU/L, participants using a sys-
tem from the manufacturer F138 detect amounts of
around 0–40 kU/L and the systems from manufac-
turer F48 display a far wider variation of 5–65 kU/L
for the same sample. A similar situation occurs for the
diluted sample: While F7, F62, F145, and F148 have
mostly low results, ranging from 0 to 2 kU/L, a major-
ity of the participants using a system from F48 obtain
results that are two to seven times higher (between
0.75 and 7.5 kU/L). Here, the results of the two main
suppliers F64 and F138 reveal only small differences
in contrast to the “low value group” (F7, F62, F145,
F148).
Since F7, F48, F64, and F138 provide detection sys-
tems used by around 80% of all participants, this pa-
per will focus on these four manufacturers with regard
to the timelines and the analysis of the coefficient of
variation (CV).
Analysis of manufacturer distribution for birch pollen
For birch pollen, the high values obtained using the
detection systems from F48 did not only appear in
April 2015, but can be observed for all RRTs for both
the high level (Fig. 2a) and the diluted sample (Fig. 2b).
With the concentrated sample there is consistently
a large gap between the results of F48 and the next
supplier collective F138. At the same time, the values
obtained from manufactures F64 and F7 hardly ever
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Fig. 4 Timelineof the resultsof sIgEagainstwaspvenomaller-
gensfrom2010to2015forsemiquantitativeanalysisofconcen-
trated(a)anddilutedsample(b)aswellasfortheRASTclassesof
concentrated (c) anddiluted sample (d). Thegreyboxesdisplay
all results from the respective round robin test. The results ob-
tained with the specific manufacturer collectives are illustrated
ascolored10–90percentileboxplots. F7iscoloredblue,F48or-
ange, F64 red, andF138green
exceed 20 kU/L and have a low distribution within the
collective (except for F64 in January 2014). For the di-
luted sample, only F48 exhibits a noticeable difference
to the other three suppliers in most of the times.
The large differences between the semiquantitative
values also impact the classes, especially in the case of
the concentrated sample (Fig. 2c). The differences for
the diluted sample are not as severe and the results
of all manufacturers collectives lie within 1.5 classes
(Fig. 2d).
Analysis of manufacturer distribution for bee venom
Participants that used the systems provided by F48 of-
ten reached their systems saturation point (100 kU/L)
and thus exhibit a low value distribution. In the RRTs
from April 2010 to May 2011 they have the highest sIgE
values of all distributors. They also detect high values
in some other RRTs, but this time below those of the
F138 collective. Interestingly, the F64 group displays
high values when the general amount of sIgE is high,
but has the lowest values when the general sIgE values
(of all manufacturers combined) are below 40 kU/L.
F138 tends to have higher values with the exception of
the RRTs in July 2014 and April 2015 where they have
even lower values than F7 (Fig. 3a). Within the classes,
F7 and F64 mainly display a value distribution, while
F48 and F138 often detect one class (Fig. 3c).
sIgE results for the RRTs in the diluted sample are
relatively low between January 2010 and May 2014.
Later, the values as well as the range increase signif-
icantly. F64 is the only collective that displays high
values from July 2014 onwards (Fig. 3b).
Once the quantitative results are converted into
the allergen class system, the low F64 sIgE values are
mostly below the cut-off point for an allergy diagno-
sis before they suddenly rise in July 2014 and range
at least one class above the other three manufactur-
ers (Fig. 3d). As for the concentrated sample, F48 and
F138 mostly detect one class, while F7 and F64 exhibit
a value distribution (Fig. 3d).
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Table 1 Chronological developmentof thecoefficientsof variation (CVs) for semiquantitativeanalysisofbeevenomfor thecon-
centrated (High) aswell as thediluted sample (Low). Values that exceed20%arehighlighted inbold
Round robin
test
CV [%] F7 CV [%] F48 CV [%] F64 CV [%] F64-4 CV [%] F64-6 CV [%] F138
– High Low High Low High Low High Low High Low High Low
January 2010 46 177 33 14 37 142 0 – 37 142 12 25
April 2010 42 54 14 14 102 48 36 30 54 58 16 15
October 2010 37 41 15 15 120 120 37 134 56 57 11 9
January 2011 38 75 25 28 131 54 80 45 40 22 8 9
May 2011 57 277 10 15 35 57 57 15 28 61 23 13
October 2011 36 57 19 24 43 115 12 39 0 34 17 420
January 2012 25 52 0 13 28 97 – – 0 78 14 43
May 2012 83 86 19 22 27 263 31 7 21 263 22 11
October 2012 7 61 0 21 23 35 0 12 0 36 18 445
January 2013 5 56 0 18 0 90 – – 0 90 16 400
April 2013 25 85 0 28 23 60 15 74 0 44 14 11
July 2013 0 68 16 24 47 343 11 226 1 451 13 13
October 2013 39 148 28 20 57 92 26 44 20 108 14 92
January 2014 44 191 16 18 46 46 86 43 32 44 12 10
May 2014 15 42 12 175 41 138 3 68 12 64 0 12
July 2014 60 55 17 15 44 53 24 34 10 32 16 14
October 2014 21 107 18 23 40 45 2 30 11 19 15 14
January 2015 26 46 14 17 40 52 8 19 2 22 13 174
April 2015 29 37 28 23 37 51 5 30 7 31 20 22
Analysis of manufacturer distribution for wasp
venom
In contrast to the other two allergen sources, sIgE lev-
els for wasp venom hardly exceed 30 kU/L. Only two
of the 19 RRTs detect sIgE up to 50 kU/L (Fig. 4a).
Another difference is the value distribution of the
F7 collective; it exhibits the highest sIgE concentra-
tions for both samples in most of the RRTs except for
those between April 2010 and January 2012. Surpris-
ingly, F48 only displays its highest values in the con-
centrated sample from April 2010 to May 2011 and
in the diluted sample in October 2014. In the other
RRTs, the collective’s values fall between those of F64
and F7/F138. F64 shows the lowest results for the con-
centrated sample in all RRTs. In the diluted sample,
there are also low values for the RRTs until July 2014,
but later they are comparable to F7 (Fig. 4a, b).
If the semiquantitative results are converted into al-
lergen classes, F138 once again mainly shows results
within one class. F48 displays a greater distribution
and F64 exhibits the lowest results once again. F64
is the only supplier with a high incidence of results
below allergen class 1 in the diluted sample, thus in-
dicating no allergy. After May 2014, there is no gen-
eral manufacturer-dependent tendency to have aller-
gen classes below class 1 (Fig. 4c, d).
Quality development for in vitro allergen diagnostics
for bee venom
The wide range in box plots within the diagrams
above, especially for the semiquantitative analysis,
indicates low interlaboratory comparability for some
supplier collectives. The CVs were exemplarily gen-
erated for the semiquantitative sIgE results for bee
venom (Table 1) and are comparable to the other two
allergen sources. CVs that exceed the critical quality
mark of 20% [6] are highlighted in red.
F7 often achieves CVs that are higher than 20% for
most of the concentrated samples and even above 30%
for the diluted samples. Only four RRTs are able to
achieve CVs below the critical mark.
Collective F64 exhibits similar and even higher CVs,
but only as long as the results obtained by the two dif-
ferent systems F64-4 and F64-6 are combined. Once
they are divided, the CVs strongly decrease after May
2011 for the concentrated sample, but hardly ever do
this for the diluted one.
The only suppliers that mostly display CVs below
20% for both samples are F48 and F138 with a few
spikes in some years.
All manufacturer collectives show spikes above
100% for several RRTs and even some CVs of 0%. The
low values correlate to the RRTs where high amounts
of sIgE for bee venom are detected (cp. Fig. 3a, b) and
the supplier collectives reach the saturation point of
the systems used.
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When the IgE values are displayed in allergen
classes, all of the manufacturers analyzed have CVs
below 20% (data not shown).
Discussion
After the initial reports about the wide system-depen-
dent differences in the amounts of sIgE detected, im-
provements in the allergy diagnostics became neces-
sary. Many attempts have been made since then, from
both a regulatory and a supplier perspective, includ-
ing mandatory participation in RRTs twice a year [15]
and the generation of calibration samples in line with
the WHO standard 75/502.
The aim of this study was to align the different de-
tection systems in order to improve in vitro allergy
diagnostics and general research. Therefore, the data
from the last six years of INSTAND e. V. were used
to examine the status quo. Unfortunately, there re-
mains a stark difference between the results of the four
most prominent suppliers for the important allergen
sources birch pollen, bee venom, and wasp venom.
For the outdoor allergen source birch pollen, the
collective F48 detects significantly higher values than
the other three, while F7 and F64 always display low
results for sIgE. We are able to show that within 2010
and 2015 no efforts have been made to align results.
The reasons for these differences remain un-
changed: The use of different analytical systems is
one factor, but the major reason is most probably the
vast complexity of allergen extracts and sIgE binding
epitopes on the allergens. For example, the major
birch pollen allergen Bet v1 indicates at least four to
six different isoforms in the pollen of an individual
tree [16]. Using recombinant proteins could present
a more consistent basis for generating assays even
though different isoforms of rBet v1 also exist (e. g.,
[17–19]). As long as the suppliers are not using the
same mixture to generate and calibrate the system,
the current detection differences are likely to remain.
The use of single proteins for the systems as only
indicators for sensitization is also not recommended
since there are regional variations in the reactiv-
ity to different birch pollen proteins within Europe.
Movérare et al. was able to show that around 98%
of patients sensitive to birch pollen in Sweden, Fin-
land, and Austria had sIgE against Bet v1, while the
percentage in Switzerland and northern Italy was
only 70% [20]. Nevertheless, a mixture of different
(recombinant) pure proteins might improve the gen-
eral comparability, even though regional specialties
should be considered for different mixtures. Further-
more, the general allergen amounts should be kept in
mind, to prevent false positive results.
Hymenoptera venoms are a special allergen source,
not only because of the high risk of life-threatening
anaphylaxis, but also due to the elevated number of
negative results within the diagnostic workup. About
15–20% of the patients with both a positive medical
history and skin test have negative in vitro results.
Furthermore, the sIgE values do not correlate to the
severity of the clinical symptoms [21–23]. The skin
tests results might be considered more stable, but
there are negative results, even when symptoms oc-
cur. Golden et al. suggest that 30% of patients allergic
to hymenoptera venommight have a negative skin test
result because of the limited sensitivity of the reagents
used [24].
A negative in vitro result in an allergy diagnosis
is defined as an sIgE level below 0.35 kU/L (aller-
gen class 1). Among the INSTAND e. V. data, only
supplier F64 showed an overwhelming tendency to
produce sIgE results below this critical mark for both
bee and wasp venom between January 2010 and May
2014. The three other manufacturer collectives de-
tected higher amounts and thus a sensitization. After
May 2014, the detection levels from F64 suddenly rose
and were the highest for bee venom and equivalent to
F7 for wasp venom. This indicates that the manu-
facturer has made some changes to its systems. This
alteration could be due to the use of new venom aller-
gen standards. There are reports that major allergens
are missing or underrepresented in the hymenoptera
venom standards, e. g., Ves v5 in the wasp venom ex-
tract [25] and Api m10 in the bee venom standard [26].
The importance of these insufficiently represented al-
lergens was shown by Vos et al., who were able to
increase sensitivity to an assay from 84.4 to 96.8% by
spiking the extract with recombinant (r) Ves v5 [25].
F48 also had one noticeable shift in the general de-
tection tendency: From January 2010 until May 2011
they displayed the highest sIgE values for both hy-
menoptera venoms. In terms of the bee venom, there
was a huge gap between the F48 results and the next
in line. However, after October 2011, they detected
average results.
The high values for both manufacturers F48 and
F64 were possibly due to more potent IgE-binding ex-
tracts or because of an enhanced cross-reactivity of
their standards. There are high similarities between
different proteins within the hymenoptera venoms,
for example, between the honeybee protein Api m2
and the wasp protein Ves v2 [27]. Furthermore, cross-
reactive carbohydrate structures (CCDs) present a se-
rious problem in the hymenoptera venom allergy di-
agnostic [28, 29] and they can react to different hy-
menoptera venoms as well as to other allergen sources
[30–32].
The CCD dependent cross-reactivity can be elim-
inated by the use of recombinant proteins produced
in bacteria [33]. However, CCD-independent cross-re-
activities still remain, as shown by different research
groups (e. g., [34–36]).
Koch & Aberer evaluated the allergen class results
for sIgE and they reported a very good comparability
between the participants over the last 25 years in Aus-
tria (and since 2006 in neighboring countries). These
results are mainly due to the fact that only the allergen
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classes were evaluated. Furthermore, their criteria for
a “false” result was less strict than those of INSTAND
e. V.: It was only considered “false” if it differed more
than two classes from the overall results or was nega-
tive, while the mainstream showed a sensitization. Es-
pecially within the higher classes (above 3), the value
span is quite high; so many differences, as we could
observe within our analysis, simply vanished due to
the focus on the allergen classes [12]. The importance
of the evaluation of the semiquantitative values was
pinpointed by Wood et al. as well: They compared the
results from two established laboratories within the
USA and showed high differences between the three
methods evaluated, once it comes down to the semi-
quantitative results [5].
This further highlights the semiquantitative basis
of the detection systems as a general problem in in
vitro allergy diagnostics. This means it is currently
impossible to determine which collective detects the
“almost true sIgE values”. The development of a fully
characterized serum sample or a “serum-like” sample
with defined spikes of sIgE is one possible solution to
this problem. Chimeric antibodies might be a big help
to provide these spikes, as shown by Wood et al., who
used this kind of antibodies to evaluate the origin of
the differences between the results from various man-
ufacturers. Their findings also indicated a low com-
parability of the detected values for sIgE to the WHO
standard, since the sIgE-results provided by some sys-
tems show a huge deviation from the total IgE results
[5]. So the question arises whether the calibration
curves are correct? A further advantage of an “arti-
ficial serum sample” with chimeric antibodies might
be that there is no interference to epitope specific IgG
antibodies.
Once the true values are known, suppliers who de-
tect the wrong result have no other choice but to cor-
rect their system. By using monoclonally engineered
sIgE, one could also enlarge the allergen source pool
to the other hymenoptera species where no allergen
extracts presently exist. Currently, a sensitization to
the bumblebee and hornet are most likely to be de-
tected as an allergy to bee venom due to the high
cross-reactivity [28].
While the analysis of the RRTs not only reveals that
there is still a poor consensus between the different
manufacturers, it also provides insight into the per-
formance of the individual laboratories as well as the
robustness of the assays. A comparison of the CV for
the individual collectives is a good indicator of inter-
laboratory comparability.
Even though they showed higher sIgE values than
most other suppliers, the CVs of F48 and F138 were
around, or even below, the “critical” quality mark of
20%, with the exception of a few spikes, especially
within the diluted sample. This tendency remained
constant over the six year study period, indicating
a generally robust system as well as a good manage-
ment of production quality.
F64 showed high CVs that usually diminished once
the results were divided into the two different detec-
tion systems. Within the concentrated sample, there
were very low CVs, including zero values. These low
CVs correlated with the RRTs that displayed a gen-
eral tendency for high sIgE values (cp. Fig. 3a) and
where the F64 collectives mostly reached their satu-
ration points. Once the diluted sample was analyzed,
only few RRTs achieved CVs below 20% for the two dif-
ferent F64 systems, indicating an unstableness within
lower sIgE results.
F7 showed high CVs in general with a few excep-
tions where all participants reached the highest cal-
ibration point of their detection system. Within the
diluted sample, there was no RRT with a CV below
30%. This might be a promising tendency, since the
CVs dropped during 2015, but such low values had
occurred from time to time in the past as well. A con-
stant observation is needed to ensure that this good
tendency remains constant in the future.
The high results for the CVs of F7 and F64 (>20%)
were relatively surprising since other publications
have reported CVs of 20% and below for different
systems [6, 7]. The high values presented in this
publication might be due to the fact that the data
includes all results provided by the participants of the
respective RRT. Only values that exceeded the calibra-
tion by more than 20% were excluded since they were
more likely to be transfer errors. Nevertheless, there
were still outliers present in some RRTs that were up
to 30 times higher than the median. A high num-
ber of participants, as described in this publication,
increases the probability of those outliers.
The results of the allergen classes presented here
were expected to be good, since a wide range of high
values were only exhibited in one class, so even a dif-
ference of 20 kU/L would not have changed the class.
The manufacturer-dependent differences are not
only present for the birch pollen and the hymenoptera
venoms, but also for food allergens [37] and other in-
haled allergen sources like house dust mite and cat
epithelium [38].
Conclusion
In summary, this publication shows that there are still
large supplier differences, most likely due to the use of
complex allergen extracts instead of defined allergen
compounds. The use of defined proteins, like recom-
binant constructs, might not solve this problem since
different isoforms exist here as well. Thus, further re-
search is needed. The quality of the performance is
good in the case of F48 and F138, but there is a dire
need of improvement in the case of F7 and F64. IN-
STAND e. V. will contact these suppliers to address the
problem and offer help in finding a solution.
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